Gryphon Financial Partners’s Celgene Corp CELG Stock Holding History

Gryphon Financial Partners’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,446	Closed	-$243K	–	183
2019 Q3	$243K	Sell	2,446 -6	-0.2%	-$570	0.07%	144
2019 Q2	$227K	Buy	2,452 +23	+0.9%	+$2.18K	0.07%	135
2019 Q1	$230K	Buy	+2,429	New	+$212K	0.07%	112
2018 Q4	–	Sell	-2,923	Closed	-$262K	–	235
2018 Q3	$262K	Buy	2,923 +2,596	+794%	+$229K	0.08%	126
2018 Q2	$26K	Sell	327 -44	-12%	-$3.65K	0.01%	339
2018 Q1	$33K	Sell	371 -309	-45%	-$29.7K	0.02%	297
2017 Q4	$71K	Buy	+680	New	+$76.7K	0.04%	192

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Gryphon Financial Partners's CELG Position: Q4 2019 in Review

Gryphon Financial Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,446 shares — an estimated $243K sold.

Gryphon Financial Partners first reported a position in CELG in Q4 2017 and held it in 7 quarters. The position peaked at $262K in Q3 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Gryphon Financial Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Gryphon Financial Partners sold 2,446 Celgene Corp shares in Q4 2019, an estimated $243K.
Gryphon Financial Partners first reported a position in Celgene Corp in Q4 2017 and held it in 7 quarters.
Gryphon Financial Partners's Celgene Corp position peaked at $262K in Q3 2018.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Gryphon Financial Partners's 13F filing for Q4 2019, filed 6 Feb 2020.